SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

ARCA biopharma, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ABIO News...
Health Technology » Biotechnology
GILDGilead Sciences, Inc.
AMGNAmgen Inc.
BIIBBiogen Inc.
CELGCelgene Corporation
ILMNIllumina, Inc.
REGNRegeneron Pharmaceuticals, Inc.
SRPTSarepta Therapeutics, Inc.
ALXNAlexion Pharmaceuticals, Inc.
INCYIncyte Corporation
CLVSClovis Oncology, Inc.
VRTXVertex Pharmaceuticals Incorporated
EXELExelixis, Inc.
BMRNBioMarin Pharmaceutical Inc.

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. ARCA biopharma was founded in 1992 and is headquartered in Westminster, CO.